Phase III Randomized Study of Ensartinib vs Crizotinib in Anaplastic Lymphoma Kinase (ALK) POSITIVE NSCLC Patients: eXalt3
文献类型：期刊论文
| 作者 | Selvaggi, G.2; Wakelee, H. A.3; Mok, T.4; Wu, Y. -L.5,6; Reck, M.7; Chiappori, A.1; Cicin, I.8; Lee, D. H.9; Breder, V.10; Fan, Y.11 |
| 刊名 | JOURNAL OF THORACIC ONCOLOGY
 |
| 出版日期 | 2020-10-01 |
| 卷号 | 15 |
| ISSN号 | 1556-0864 |
| 关键词 | ALK plus NSCLC ensartinib Crizotinib |
| WOS研究方向 | Oncology ; Respiratory System |
| 语种 | 英语 |
| 出版者 | ELSEVIER SCIENCE INC |
| WOS记录号 | WOS:000569266100003 |
| 源URL | [http://ir.hfcas.ac.cn:8080/handle/334002/104100]  |
| 专题 | 中国科学院合肥物质科学研究院 |
| 作者单位 | 1.H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA 2.Xcovery Holdings Inc, Palm Beach Gardens, FL USA 3.Stanford Univ, Dept Med, Stanford Canc Inst, Div Oncol, Stanford, CA 94305 USA 4.Chinese Univ Hong Kong, Hong Kong, Peoples R China 5.Guangdong Prov Peoples Hosp, Guangzhou, Peoples R China 6.Guangdong Acad Med Sci, Guangzhou, Peoples R China 7.Airway Res Ctr North ARCN, Lung Clin, Grosshansdorf, Germany 8.Trakya Univ, Edirne, Turkey 9.Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea 10.Minist Hlth Russian Federat, NN Blokhin Natl Med Res Ctr Oncol, Moscow, Russia |
| 推荐引用方式 GB/T 7714 | Selvaggi, G.,Wakelee, H. A.,Mok, T.,et al. Phase III Randomized Study of Ensartinib vs Crizotinib in Anaplastic Lymphoma Kinase (ALK) POSITIVE NSCLC Patients: eXalt3[J]. JOURNAL OF THORACIC ONCOLOGY,2020,15. |
| APA | Selvaggi, G..,Wakelee, H. A..,Mok, T..,Wu, Y. -L..,Reck, M..,...&Liang, C..(2020).Phase III Randomized Study of Ensartinib vs Crizotinib in Anaplastic Lymphoma Kinase (ALK) POSITIVE NSCLC Patients: eXalt3.JOURNAL OF THORACIC ONCOLOGY,15. |
| MLA | Selvaggi, G.,et al."Phase III Randomized Study of Ensartinib vs Crizotinib in Anaplastic Lymphoma Kinase (ALK) POSITIVE NSCLC Patients: eXalt3".JOURNAL OF THORACIC ONCOLOGY 15(2020). |
入库方式： OAI收割
来源：合肥物质科学研究院
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。